European CHMP recommends paediatric license extension and new formulation of dolutegravir (Tivicay)

Paediatric license extension is in combination with other anti-retroviral medicinal products for treatment of HIV infected patients at least 4 weeks of age or older and weighing at least 3 kg and is supported by a new pharmaceutical form and strength – 5mg dispersible tablets.

Source:

European Medicines Agency